Investor Relations
Welcome to our dynamic visualization of the ongoing projects at Kamat Pharmatech. Below, you'll find a comprehensive table representing the current status of each project within our development pipeline. Each entry is color-coded to reflect its current stage of completion, allowing for an at-a-glance understanding of our progress and ongoing efforts. | Pipeline Item | Pipeline Milestones | | Regulatory Type | Dosage Form | Product Development | Technology Transfer | Regulatory Process | Commercialization | 1 | ANDA | Oral Suspension | | | | | | | | | | | | | | | | | | 2 | 505(b)2 | Oral Solution | | | | | | | | | | | | | | | | | | 3 | ANDA | Long-Acting Injectable (LAI) | | | | | | | | | | | | | | | | | | 4 | ANDA | Lyophilized Vial | | | | | | | | | | | | | | | | | | 5 | ANDA | Lyophilized Vial | | | | | | | | | | | | | | | | | | 6 | ANDA | Ready-to-Use Injectable | | | | | | | | | | | | | | | | | | 7 | ANDA | Injectable | | | | | | | | | | | | | | | | | | 8 | ANDA | Topical | | | | | | | | | | | | | | | | | | 9 | ANDA | Topical | | | | | | | | | | | | | | | | | | 10 | ANDA | Topical | | | | | | | | | | | | | | | | | | 11 | ANDA | Topical | | | | | | | | | | | | | | | | | | 12 | 505(b)2 | Oral Suspension | | | | | | | | | | | | | | | | | | 13 | ANDA | Topical | | | | | | | | | | | | | | | | | | 14 | ANDA | Topical | | | | | | | | | | | | | | | | | | 15 | ANDA | Topical | | | | | | | | | | | | | | | | | | 16 | ANDA | Topical | | | | | | | | | | | | | | | | | | 17 | ANDA | Topical | | | | | | | | | | | | | | | | | | 18 | ANDA | Topical | | | | | | | | | | | | | | | | | | 19 | ANDA | Topical | | | | | | | | | | | | | | | | | | 20 | OTC | Oral Tonic | | | | | | | | | | | | | | | | | | 21 | OTC | Topical | | | | | | | | | | | | | | | | | | 22 | 505(b)2 | Nasal Spray | | | | | | | | | | | | | | | | | |
ANDAs | 505(B)2s | OTC Products | Total | 0 | 0 | 0 | 0 |
We are actively expanding our capabilities through the development of a microsphere technology platform and specialized product manufacturing based in the US. Beyond our commercial ventures, we are committed to fostering innovation by supporting a select group of basic science projects and pioneering new product developments. If you're interested in collaborating on any of these initiatives, please don't hesitate to contact us. Upon signing a non-disclosure agreement (NDA), we can disclose further details and explore the possibility of collaboration. |